2-(2-Hydroxyethoxy)isoindoline-1,3-dione

Catalog No.: 
ACTKXN587
CAS No.: 
32380-69-1
Molecular Formula: 
C10H9NO4
Molecular Weight: 
207.18
2-(2-Hydroxyethoxy)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$58.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Hydroxyethoxy)isoindoline-1,3-dione
IUPAC Name2-(2-hydroxyethoxy)isoindoline-1,3-dione
MDL No.0
Molecular FormulaC10H9NO4
Molecular Weight207.18
SMILESO=C1N(OCCO)C(C2=C1C=CC=C2)=O
InChI KeyDOSUQMBAMQLTFF-UHFFFAOYSA-N
Synonym2-(2-Hydroxyethoxy)isoindoline-1.3-dione;2-(2-hydroxyethoxy)-1H-Isoindole-1,3(2H)-dione;1H-Isoindole-1,3(2H)-dione, 2-(2-hydroxyethoxy)-;2-(2-hydroxyethoxy)isoindole-1,3-dione
CAS No.32380-69-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACTKXN587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACTKXN587 route product structure diagram
    ACTKXN58732380-69-1In Stock
Inquiry

2. ACTKXN587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTKXN587 route product structure diagram
    ACTKXN58732380-69-1In Stock
Inquiry

3. ACTKXN587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTKXN587 route product structure diagram
    ACTKXN58732380-69-1In Stock
Inquiry

Comments (0)